JPMorgan sets Palantir (PLTR) stock price target for 12 months
JPMorgan's Brian Essex initiated coverage on Palantir (PLTR) with an 'Overweight' rating and a 12-month price target of $262, implying a 31.98% rise. The bullish outlook is based on Palantir's operational momentum and 12 quarters of revenue growth, reaching 93% year-over-year to $1.93 billion. Barclays and Oppenheimer also issued 'Buy' ratings with targets of $265 and $235, respectively. The average 12-month price target among analysts is $218.95.
How this was made
The 30-second read
Why it matters
The consensus of high targets could drive short‑term buying pressure before earnings.
Market read
New analyst targets create bullish bias for PLTR ahead of its earnings release.
What to watch
Potential execution risk on AI contracts and macro‑rate environment.
Background
Analyst coverage initiation ahead of Q3 earnings, with multiple firms issuing new price targets.
Ticker impact
JPMorgan initiated coverage with an Overweight rating and a 12‑month price target of $262, implying ~32% upside.
likely upward pressure as investors price in the implied upside
The new target is a primary disclosure and represents a material upside expectation for the stock.
Market effects
May lift sentiment across AI‑focused software stocks.
Limited to U.S. tech equities.
Minor, confined to Palantir and peers.
Counterpoint
Target may be overly optimistic given recent valuation levels.
Key entities
- analystJPMorgan Chase & Co.
Initiated coverage with Overweight rating and $262 target.
- analystBarclays PLC
Reiterated Buy rating with $265 target.
- analystOppenheimer
Raised target to $235.
